AQP4 and myeloid sarcoma: Even urine metabolites, which drive the separation between MS patients, anti-AQP4 positive NMOSD patients and healthy controls, have been related to alterations in energy and FAs metabolism, mitochondrial activity and the gut microbiota [45].